Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
QLIFE.STthis companyQlife Holding AB (publ)	SEK 0.94	-1.73×	-4.74×	109.73×	-2.68×	-190.0%	-5590.7%	-5982.7%	-6345.1%	273.8%	-279.6%	-60.4%	-1.92×	-0.72×	-16.51×	0.56×	0.0%	4	-34.91	1	D+
AINO.STAino Health AB (publ)	SEK 0.18	-5.72×	-5.45×	1.34×	-11.4×	9.1%	-16.4%	-20.0%	-23.4%	95.1%	-278.5%	-6.9%	-1.3×	-0.77×	-6.08×	0.89×	0.0%	3	-0.85	2	C
EPIS-B.STEpisurf Medical AB	SEK 0.05	-0.63×	0.77×	2.71×	-0.74×	-817.4%	-429.6%	-447.4%	-431.1%	-122.5%	-115.3%	-169.4%	0.14×	0.01×	-100.67×	1.7×	0.0%	4	-0.62	2	C
FLUI.STFluicell AB (publ)	SEK 25.90	-1.65×	1.26×	2.29×	-1.38×	-381.5%	-144.7%	-144.7%	-138.8%	-76.4%	-79.7%	-99.1%	0×	0.27×	-45×	1×	0.0%	3	-3.05	3	B+
ODI.STODI Pharma AB	SEK 1.33	21.82×	18.52×	1.34×	15.65×	-2478.3%	31.2%	7.6%	6.0%	83.7%	105.4%	10.4%	0×	-1.31×	4.15×	1.81×	0.0%	6	13.25	3	B-
PROGEN.STProstatype Genomics AB (publ)	SEK 0.10	-0.23×	0.38×	17.06×	-0.17×	-371.4%	-6332.7%	-6579.1%	-7492.1%	-167.8%	-122.8%	-237.4%	0.2×	0.1×	-24.2×	0.44×	0.0%	2	-3.97	2	C
Peer median	—	-0.63×	0.77×	2.29×	-0.74×	-381.5%	-144.7%	-144.7%	-138.8%	-76.4%	-115.3%	-99.1%	0×	0.01×	-24.2×	1×	0.0%	3	-0.85	2	—